Immuron Ltd ADR

Immuron Ltd ADR Net Margin

The Net Profit Margin of Immuron Ltd ADR (IMRN) as of Nov 3, 2026 is -49.77 %. In the previous year, Net Profit Margin was -71.58 % — a change of -30.48% (higher).

Net Margin

-49.77 %

YoY

-30.48%

Last updated:

Net Profit Margin of Immuron Ltd ADR is 2026 -49.77 % . Net Profit Margin of Immuron Ltd ADR was 2025 -71.58 % . It decreases by -30.48% higher compared to the previous year.

For Immuron Ltd ADR, the net margin of -49.8% is up versus -373.0% a few years ago.

The Immuron Ltd ADR Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2019
-195.04 USD
Jan 1, 2020
-115.33 USD
Jan 1, 2021
-5,751.61 USD
Jan 1, 2022
-373.01 USD
Jan 1, 2023
-209.81 USD
Jan 1, 2024
-141.49 USD
Jan 1, 2025
-71.58 USD
Jan 1, 2026
-49.77 USD
The Immuron Ltd ADR Net Margin history
YEARNet MarginYoY
-49.77 %-30.48%
-71.58 %-49.41%
-141.49 %-32.56%
-209.81 %-43.75%
-373.01 %-93.51%
-5,751.61 %+4,886.88%
-115.33 %-40.87%
-195.04 %+19.38%
-163.38 %-66.47%
-487.33 %-30.98%
-706.12 %+162.94%
-268.54 %0.00%
-268.54 %+1,036.32%
-23.63 %+361.86%
-5.12 %-57.82%
-12.13 %+193.98%
-4.13 %-6.70%
-4.42 %-54.68%
-9.76 %+1,163.78%
-0.77 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Immuron Ltd ADR Stock analysis

What does Immuron Ltd ADR do? Immuron Ltd ADR is a biopharmaceutical company listed on the US market in 2017, operating from Carlton. The firm engages in the research, development, and commercialization of polyclonal antibodies across Australia, the United States, and Canada. It operates through Research and Development and Hyper-immune Products segments. Immuron offers Travelan, an over-the-counter medicine and dietary supplement for digestive health, and Protectyn, an immune supplement. The company also develops clinical-stage candidates, including Travelan (IMM-124E) and IMM-529 for gastrointestinal conditions, alongside the pre-clinical IMM-986. Additionally, Immuron provides a technology platform and maintains collaborations for therapeutic development. Immuron Ltd ADR is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Immuron Ltd ADR stock

Net Profit Margin of Immuron Ltd ADR is -49.77 % in 2026.

Net Profit Margin of Immuron Ltd ADR changed from -71.58 % to -49.77 %, representing a -30.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Immuron Ltd ADR since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Immuron Ltd ADR with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Immuron Ltd ADR

All Key Metrics — Immuron Ltd ADR